1.Phytochemical and pharmacological advance on Tibetan medicinal plants of Corydalis.
Wei-Qing SHANG ; Yue-Mei CHEN ; Xiao-Li GAO ; Chi PU ; Peng-Fei TU ; Xing-Yun CHAI
China Journal of Chinese Materia Medica 2014;39(7):1190-1198
It was estimated that about 428 species of genus Corydalis are distributed all worldwide, with about 298, especially 10 groups and 219 species being uniquely spread in China. The genus Corydalis have been widely employed as folk medicines in China, especially as traditional Tibetan medicines, for treatment of fever, hepatitis, edema, gastritis, cholecystitis, hypertension and other diseases. The phytochemical studies revealed that isoquinoline alkaloids are its major bioactive ingredients. The extensive biological researches suggested its pharmacological activities and clinic applications against cardiovascular diseases and central nervous system, antibacterial activities, analgesic effects, anti-inflammatory, anti-oxidation and anti-injury for hepatocyte, and so on. As an effort in promoting the research of pharmacodynamic ingredients, this article presents an overview focusing on the distribution, phytochemical and pharmacological results of Corydalis species that have been applied in traditional Tibetan medicinal, hopefully to provide a reference for the new Tibetan medicine development from Corydalis plant resource.
Alkaloids
;
chemistry
;
pharmacology
;
Animals
;
Anti-Infective Agents
;
chemistry
;
pharmacology
;
Corydalis
;
chemistry
;
classification
;
Drugs, Chinese Herbal
;
chemistry
;
pharmacology
;
Humans
;
Mice
;
Molecular Structure
;
Phytotherapy
2.Establishment and application of an artificial intelligence diagnosis system for pancreatic cancer with a faster region-based convolutional neural network
Liu SHANG-LONG ; Li SHUO ; Guo YU-TING ; Zhou YUN-PENG ; Zhang ZHENG-DONG ; Li SHUAI ; Lu YUN
Chinese Medical Journal 2019;132(23):2795-2803
Background: Early diagnosis and accurate staging are important to improve the cure rate and prognosis for pancreatic cancer.This study was performed to develop an automatic and accurate imaging processing technique system,allowing this system to read computed tomography(CT)images correctly and make diagnosis of pancreatic cancer faster.Methods: The establishment of the artificial intelligence(AI)system for pancreatic cancer diagnosis based on sequential contrast-enhanced CT images were composed of two processes: training and verification.During training process,our study used all 4385 CT images from 238 pancreatic cancer patients in the database as the training data set.Additionally,we used VGG16,which was pre-trained in ImageNet and contained 13 convolutional layers and three fully connected layers,to initialize the feature extraction network.In the verification experiment,we used sequential clinical CT images from 238 pancreatic cancer patients as our experimental data and input these data into the faster region-based convolution network(Faster R-CNN)model that had completed training.Totally,1699 images from 100 pancreatic cancer patients were included for clinical verification.Results: A total of 338 patients with pancreatic cancer were included in the study.The clinical characteristics(sex,age,tumor location,differentiation grade,and tumor-node-metastasis stage)between the two training and verification groups were insignificant.The mean average precision was 0.7664,indicating a good training effect of the Faster R-CNN.Sequential contrast-enhanced CT images of 100 pancreatic cancer patients were used for clinical verification.The area under the receiver operating characteristic curve calculated according to the trapezoidal rule was 0.9632.It took approximately 0.2 s for the Faster R-CNN AI to automatically process one CT image,which is much faster than the time required for diagnosis by an imaging specialist.Conclusions: Faster R-CNN AI is an effective and objective method with high accuracy for the diagnosis of pancreatic cancer.
3.Expression of E-cadherin in nasopharyngeal carcinoma and its relationship with cervical lymph node metastasis.
Qing LIU ; Ya-di WANG ; Shang-Hua JING ; Xiao-Ling WANG ; Yun-Jie CHENG ; Feng-Peng WU
Chinese Journal of Oncology 2010;32(6):425-428
OBJECTIVETo investigate the expression of E-cadherin in nasopharyngeal carcinoma (NPC) and its relationship with cervical lymph node metastasis.
METHODSThe expression of E-cadherin in 80 patients with NPC was detected by immunohistochemistry.
RESULTSLower expression of E-cadherin was associated with advanced N-stage of the tumor (P = 0.018). There was no significant correlation between the expression of E-cadherin and lymph node size (P = 0.435). The expression of E-cadherin was higher in patients with cervical lymph node metastasis limited to a single area than that distributing in some scattered areas (P = 0.000). There was a trend that the expression of E-cadherin in the cases with the tumor and lymph nodes in the same side was higher (56.5%) than that in the patients with bilateral lymph node metastases (32.6%), however, the difference was not significant (P = 0.059). The expression rates of E-cadherin in patients with lymph node metastasis in levels II, III and Va were higher than that in levels I, IV, Vb and VI, but with a non-significant difference (P = 0.059).
CONCLUSIONThe expression of E-cadherin has influence on the lymph node metastasis in nasopharyngeal carcinoma. E-cadherin expression is negatively correlated with the numbers of the lymph node metastases and the metastasis distance, i.e. a lower expression of E-cadherin leads to an advanced N-stage. The lymph node metastasis of nasopharyngeal cancer from above to below is more considerably influenced by E-cadherin expression than the metastasis towards contralateral lymph nodes.
Adolescent ; Adult ; Aged ; Cadherins ; metabolism ; Carcinoma, Squamous Cell ; metabolism ; pathology ; Female ; Humans ; Lymph Nodes ; pathology ; Lymphatic Metastasis ; pathology ; Male ; Middle Aged ; Nasopharyngeal Neoplasms ; metabolism ; pathology ; Neoplasm Staging ; Young Adult
4.The diagnosis value of multiGparameter spectral CT imaging in fat quantitative measurement on nonalcoholic fatty liver disease
Chang LI ; Yini WANG ; Yun PENG ; Jingtao WU ; Qingqiang ZHU ; Song’an SHANG ; Wenxin CHEN ; Xianfu LUO
Journal of Practical Radiology 2019;35(6):992-996
Objective To explore the value of single source dual energy CT for quantitative measurement of liver fat fraction in the rabbit model of nonalcoholic fatty liver disease(NAFLD).Methods Thirty male New Zealand rabbits were randomly divided into five groups.Six rabbits were fed with standard chow as a control group for 3 weeks.TwentyGfour rabbits were divided into four groups and fed with highGfat, highGcholesterol diet to reach different stage of NAFLD model for 1 ,3 ,4 and 8 weeks respectively before dualGenergy CT scanning.1 40 keV polychromatic CT values (QC),70 keV monochromatic CT values (Mono 70 keV),slope,effective atomic number (EffectiveGZ)and fat concentration based on dualGenergy CT fat decomposition (Fat/Water)were measured.Liver samples were obtained to measure the fat fraction and staged according to Burnt staging system.Correlations between different CT indexes and fat fraction were analyzed.ROC was used to evaluate the diagnosis efficacy of different parameters.Results Correlation between fat concentration based on dualGenergy CT fat decomposition and fat fraction (r=0.936)was better than that between 140 keV polychromatic CT values (r=-0.838)and 70 keV monochromatic CT values (r=-0.906),as well as effective atomic number (r=-0.858)and slope (r=0.863).In terms of diagnostic performance of material decomposition fat imaging,the values of area under the curve were 0.944 (stage 0 vs.stage 1 or more severe),0.995 (stage 1 or less severe vs.stage 2 or more severe)and 1 (stage 2 or less severe vs.stage 3)with optimal cutoff values of 59.310,99.5 17 and 22 3.02 3 mg/cm3 ,respectively.Conclusion The dualGenergy CT can quantitatively measure liver fat concentration as a noninvasive surrogate bioGmarker in the rabbit model of nonalcoholic fatty liver disease.DualGenergy CT derived material decomposition fat images can provide more diagnostic information at the early stage of NAFLD.
5.Effects of Ginkgo biloba extract on number and activity of endothelial progenitor cells from peripheral blood.
Xing-xiang WANG ; Yun-peng SHANG ; Jun-zhu CHEN ; Jun-hui ZHU ; Xiao-gang GUO ; Jian SUN
Acta Pharmaceutica Sinica 2004;39(8):656-660
AIMTo investigate whether Ginkgo biloba extract can augment endothelial progenitor cell (EPC) number, and promote EPC proliferation, migration and adhesion.
METHODSTotal mononuclear cells (MNCs) were isolated from peripheral blood by Ficoll density gradient centrifugation, and then the cells were plated on fibronectin-coated culture dishes. After 7 days of culture, attached cells were stimulated with Ginkgo biloba extract (10, 25 and 50 mg x L(-1)) or vehicle control for the respective time points (6, 12, 24 and 48 h). EPC were characterized as adherent cells double positive for DiLDL-uptake and lectin binding by direct fluorescent staining under a laser scanning confocal microscope. EPC were further documented by demonstrating the expression of CD34, VEGFR-2 and AC133 with flow cytometry. EPC proliferation, migration and in vitro vasculogenesis activity were assayed with MTT assay, modified Boyden chamber assay and in vitro vasculogenesis kit, respectively. EPCs adhesion assay was performed by replating MNCs on fibronectin-coated dishes, and then counting adherent cells.
RESULTSIncubation of isolated human MNCs with Ginkgo biloba extract increased the number of EPC, maximum at 25 mg x L(-1), 24 hours (approximately 1-fold increase, P < 0.01). In addition, Ginkgo biloba extract promotes EPC proliferative, migratory, adhesive and in vitro vasculogenesis capacity.
CONCLUSIONGinkgo biloba may promote EPC augmentation and enhance its functional activity.
Cell Adhesion ; drug effects ; Cell Movement ; drug effects ; Cell Proliferation ; drug effects ; Drugs, Chinese Herbal ; isolation & purification ; pharmacology ; Endothelium, Vascular ; cytology ; drug effects ; Ginkgo biloba ; chemistry ; Humans ; Neovascularization, Physiologic ; drug effects ; Plant Leaves ; chemistry ; Plants, Medicinal ; chemistry ; Stem Cells ; drug effects
6.Effects of puerarin on number and activity of endothelial progenitor cells from peripheral blood.
Fu-Rong ZHANG ; Jun-Zhu CHEN ; Jun-Hui ZHU ; Xing-Xiang WANG ; Jian-Hua ZHU ; Yun-Peng SHANG ; Xiao-Gang GUO ; He-Min DAI ; Jian SUN
China Journal of Chinese Materia Medica 2004;29(8):777-781
OBJECTIVETo investigate whether puerarin can augment endothelial progenitor cells (EPCs) numbers, promote EPC proliferation, migration and adhesion.
METHODTotal mononuclear cells (MNCs) were isolated from peripheral blood by Ficoll density gradient centrifugation, and then the cells were plated on fibronectin-coated culture dishes. After 7 days culture, attached cells were stimulated with puerarin (to make a series of final concentrations: 0. 1, 0.5, 1, 3 mmol x L(-1)) or vehicle control for the respective time points (6, 12, 24, 48 h). EPCs were characterized as adherent cells double positive for DiLDL-uptake and lectin binding by direct fluorescent staining under a laser scanning confocal microscope. EPCs proliferation, migration and in vitro vasculogenesis activity were assayed with MT assay, modified Boyden chamber assay and in vitro vasculogenesis kit, respectively. EPCs adhesion assay was performed by replating those on fibronectin-coated dishes, then adherent cells were counted.
RESULTIncubation of isolated human MNCs with puerarin dose increased the number of EPCs, maximum at 3 mmol x L(-1), 24 hours (approximately 1-fold increase, P < 0.01). In addition, puerarin also promoted EPC proliferative, migratory, adhesive and in vitro vasculogenesis capacity.
CONCLUSIONPuerarin can augment the number of EPCs with enhanced functional activity.
Cell Adhesion ; drug effects ; Cell Division ; drug effects ; Cell Movement ; drug effects ; Cells, Cultured ; Endothelial Cells ; cytology ; drug effects ; Humans ; Isoflavones ; isolation & purification ; pharmacology ; Neovascularization, Physiologic ; drug effects ; Plants, Medicinal ; chemistry ; Pueraria ; chemistry ; Stem Cells ; cytology ; drug effects ; Time Factors ; Veins ; cytology
7.Statins contribute to enhancement of the number and the function of endothelial progenitor cells from peripheral blood.
Jun-Hui ZHU ; Qian-Min TAO ; Jun-Zhu CHEN ; Xing-Xiang WANG ; Jian-Hua ZHU ; Yun-Peng SHANG
Acta Physiologica Sinica 2004;56(3):357-364
The aim of the present study was to investigate whether fluvastatin augments the number of endothelial progenitor cells (EPCs), and promotes EPCs proliferation, migration and adhesion. Total mononuclear cells (MNCs) were isolated from peripheral blood by Ficoll density gradient centrifugation. The cells were then plated on fibronectin-coated culture dishes. After being cultured for 7 d, the attached cells were stimulated with fluvastatin (final concentrations: 0.01, 0.1, 1, 10 micromol/L), simvastatin (1 micromol/L) or a vehicle for the respective time points (6, 12, 24 and 48 h). EPCs were characterized as adherent cells double positive for DiLDL-uptake and lectin binding by direct fluorescent staining under a laser scanning confocal microscope. EPCs were further documented by demonstrating the expression of KDR, VEGFR-2 and AC133 with flow cytometry. EPCs proliferation, migration and in vitro vasculogenesis activity were assayed by MTT assay, modified Boyden chamber assay and in vitro vasculogenesis kit, respectively. EPCs adhesion assay was performed by replating it on fibronectin-coated dishes, and the adherent cells were then counted. In addition, we also studied EPCs culture assay of peripheral blood from fluvastatin-treated animals in vivo. Incubation of isolated human MNCs with fluvastatin dose- and time-dependently increased the number of EPCs, while reached the maximum 24 h after the administration at 1 micromol/L, (2.5-fold increase, P<0.05). Moreover, treatment of rats with fluvastatins elevated the number of EPCs (3-fold increase, P<0.05), thus extending the in vitro data. In addition, fluvastatin also promoted EPC proliferation, migration, adhesion and in vitro vasculogenesis in a concentration-dependent manner. The effects of fluvastatin on EPCs were compared with those of simvastatin at the same concentration (1 micromol/L), with a result of no statistical difference. The results of the present study define a novel mechanism of the action of statins: the augmentation of EPCs with enhanced functional activity.
Cell Adhesion
;
drug effects
;
Cell Count
;
Cell Movement
;
drug effects
;
Cell Proliferation
;
drug effects
;
Cells, Cultured
;
Endothelial Cells
;
cytology
;
Fatty Acids, Monounsaturated
;
pharmacology
;
Humans
;
Indoles
;
pharmacology
;
Leukocytes, Mononuclear
;
cytology
;
Simvastatin
;
pharmacology
;
Stem Cells
;
cytology
8.Cloning, expression and sequence analysis and tissue distribution of angiotensin-converting enzyme 2 (ACE2) gene in adult mice.
Xu-dong XIE ; Jun-zhu CHEN ; Xin-xiang WANG ; Jian-hua ZHU ; Jian SUN ; Ming TAO ; Yun-peng SHANG ; Xiao-gang GUO
Journal of Zhejiang University. Medical sciences 2005;34(1):48-54
OBJECTIVEo clone angiotensin-converting enzyme 2(ACE2) gene, to analyze its amino acids and nucleotides sequence and to investigate tissue distribution of ACE2 in adult mice.
METHODSThe full-length ACE2 encoding sequence was amplified from the RNA of mice kidney tissue by RT-PCR technique, cloned into plasmid pGEM-T easy, then subcloned into plasmid pcDNA3.1+. After identification of DNA sequence, the recombinant plasmid pmACE2 was transfected into Cos7 cells with lipofectin reagent. The transient expression of ACE2 molecule was detected by SDS-PAGE. Sequence analysis was conducted with CLUSTALX program. Tissue distribution of ACE2 in mice was detected by RT-PCR.
RESULTSA fragment about 2.6 kb was amplified and the recombinant plasmid pmACE2 was confirmed by two-enzyme digesting and DNA sequencing. The cloned DNA sequence was consistent with that previously reported, except for 3 variations: A701G, T1102C and T1330C. SDS-PAGE proved that expression of a soluble, truncated products form of ACE2 was a glycoprotein of approximately 80 kD in Cos7 cells. The predicted mice ACE2 sequence contained an N-terminal signal sequence (amino acid residues 1-18), a single HHEMGHIQ zinc-binding domain (amino acid residues 373-380) and C-terminal membrane anchor (amino acid residues 738-765). Mice ACE2 showed 84 % identity with that of human, and 90 % identity with that of rat. Expression of ACE2 was the greatest in lungs, hearts and kidneys, and moderate levels were also detected in testes and livers.
CONCLUSIONMice ACE2 gene has been cloned and successfully expressed in vitro. The tissue-specific expression of ACE2 in different species is not identical.
Amino Acid Sequence ; Animals ; Base Sequence ; Carboxypeptidases ; genetics ; metabolism ; Cloning, Molecular ; DNA, Complementary ; genetics ; Gene Expression ; Kidney ; metabolism ; Lung ; metabolism ; Male ; Mice ; Molecular Sequence Data ; Myocardium ; metabolism ; Peptidyl-Dipeptidase A ; Sequence Analysis ; Tissue Distribution
9.Proteomic analysis of the serum in patients with idiopathic pulmonary arterial hypertension.
Min YU ; Xing-xiang WANG ; Fu-rong ZHANG ; Yun-peng SHANG ; Yu-xi DU ; Hong-juan CHEN ; Jun-zhu CHEN
Journal of Zhejiang University. Science. B 2007;8(4):221-227
Idiopathic pulmonary arterial hypertension (IPAH) is a rare disease of unknown etiology. The exact pathogenesis of pulmonary arterial hypertension is still not well known. In the past decades, many protein molecules have been found to be involved in the development of IPAH. With proteomic techniques, profiling of human plasma proteome becomes more feasible in searching for disease-related markers. In present study, we showed the protein expression profiles of the serum of IPAH and healthy controls after depleting a few high-abundant proteins in serum. Thirteen spots had changed significantly in IPAH compared with healthy controls and were identified by LC-MS/MS. Alpha-1-antitrypsin and vitronectin were down-regulated in IPAH and may be valuable candidates for further explorations of their roles in the development of IPAH.
Blood Proteins
;
analysis
;
genetics
;
Databases, Protein
;
Electrophoresis, Gel, Two-Dimensional
;
Gas Chromatography-Mass Spectrometry
;
Humans
;
Hypertension, Pulmonary
;
blood
;
genetics
;
Proteomics
10.Application of CUA Guidelines on Prostatitis in the management of chronic pelvic pain syndrome: a nationwide survey.
Kai ZHANG ; Wen-Jun BAI ; Xue-Jun SHANG ; Yun-Xiang XIAO ; Ji-Hong LIU ; Zheng LI ; Chun-Hua DENG ; Huai-Peng WANG
National Journal of Andrology 2013;19(2):127-131
OBJECTIVETo investigate the application of the Chinese Urological Association (CUA) Guidelines on Prostatitis and its effects on the clinical practice patterns of diagnosing and treating chronic pelvic pain syndrome (CPPS) among Chinese urologists and andrologists.
METHODSWe conducted a questionnaire investigation on the application of the CUA Guidelines on Prostatitis among the urologists and andrologists of 173 hospitals in 21 cities of China, and performed statistical analyses on all the eligible questionnaires collected.
RESULTSOf the 1 056 questionnaires distributed, 851 (80.6%) were eligible, of which 71.6% were from the urologists or andrologists in grade 3 hospitals, 80.7% of them with senior or intermediate professional titles and 97.5% had studied the CUA Guidelines. Most of the subjects agreed that Type III prostatitis is a clinical syndrome, whose diagnosis should exclude other conditions with similar symptoms, and whose treatment should aim at relieving pain, alleviating urination symptoms and improving the quality of life. Those who had and those who had not studied the CUA Guidelines differed in their viewpoints on CPPS as illustrated in the book. In clinical practice, the most common treatment options for CPPS were psychological therapy (80.7%), medication (80.4%) and life style adjustment (79.6%), and the most frequently used drugs were phytotherapy (80.0%), alpha-blockers (68.9%) and antibiotics (61.0%).
CONCLUSIONCUA Guidelines on Prostatitis has gained a nationwide application and promoted the standardization of the management of CPPS in China.
Humans ; Male ; Pelvic Pain ; diagnosis ; therapy ; Physicians ; Practice Guidelines as Topic ; Prostatitis ; diagnosis ; therapy ; Surveys and Questionnaires